SEMA3C and breast carcinoma: Consistent with our clinical observations, we found that SEMA3C protein expression is significantly elevated in ER+ breast cancer cell lines, MCF7 and T47D, as compared to MCF10A, which are immortalized non-malignant breast epithelial cells that possess many characteristics of normal breast cells (Figure 2B).